Chiral calixarene-based diphosphite ligands 3a-d have been obtained via lower-rim functionalisation of the p-tert-butylcalix[4]arene core. High enantiomeric excesses (up to 94 %) and good activities were obtained in the rhodium-catalyzed asymmetric hydrogenation of prochiral olefins with TADDOL-containing diphosphites 3c,d. This is the first
The synthesis of the calix[4]arene-based P,N-ligand 3 (5,11,17,23-tetra-tert-butyl-25-[(2-quinolylmethyl)oxy]-26,27,28-(mu3-phosphorustrioxy)calix[4]arene), in which the nitrogen atom-containing moiety has been introduced at the lower rim of the cavity prior to P-functionalisation, is described and its coordination properties investigated. In the crystal structure, the calix[4]-cavity adopts a cone conformation with an exo orientation of the phosphorus lone pair enabling P-N chelation. 1H, 13C, 31P and 1H{15N} HMQC NMR spectra indicated that, in complexes [PdCl(CH3)(3)] (4) and [Rh(CO)Cl(3)] (5), ligand 3 coordinates in a chelating fashion, while in cis-[PtC12(3)2] (6) and [Rh(acac)(CO)(3)] (7) it behaves as a monodentate ligand, coordinating via the phosphorus atom only. X-Ray crystal structure determinations were performed for [PdCl(CH3)(3)] (4) and cis-[PtCl2(3)2] (6). The cationic Pd complex [Pd(CH3)(CH3CN)(3)][PF5] (8) was found to be active in a CO/ethylene copolymerisation reaction. Good selectivities were observed for the Pd-catalysed allylic alkylation of cinnamyl acetate with in situ prepared catalysts. [Rh(acac)(CO)2] modified with ligand 3 catalyses the hydroformylation of 1-octene with low selectivities towards linear aldehydes. High-pressure NMR experiments on the hydrido carbonyl rhodium(3) were inconclusive, different species were formed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.